Publication | Closed Access

Efficacy and safety of oral deferasirox treatment in the posttransplant period for patients who have undergone allogeneic hematopoietic stem cell transplantation (alloHSCT)

TransplantationMarrow TransplantationStem Cell TransplantationOral Deferasirox TreatmentGraft SurvivalBlood TransplantationPosttransplant PeriodMedicineCell TransplantationAnesthesiology